Resources for coping with cancer during COVID-19. Learn More

Prostate Cancer Drugs

Treatments can be given to cure cancer or to control or relieve symptoms. You may receive a single treatment or a combination of treatments based on your individual preferences / values and depending on the grade and stage of your cancer (i.e. how far the cancer has spread and how fast it can grow).

This section provides you with information on drugs to treat prostate cancer that are currently approved by Health Canada. As new prostate cancer drugs are approved for use in Canada we will update our information in a timely manner.

Chemotherapy Drugs

  • Cabazataxel (Jevtana®)
  • Docetaxel (Taxotere®)
  • Mitoxantrone (Teva®)

Androgen Deprivation Therapy (ADT)

  • Abiraterone Acetate (Zytiga®)
  • Apalutamide (Erleada®)
  • Bicalutamide (Casodex®)
  • Buserelin Acetate (Suprefact®)
  • Cyproterone Acetate (Androcur®)
  • Degarelix Acetate (Firmagon®)
  • Enzalutamide (Xtandi®)
  • Flutamide (Euflex®)
  • Goserelin Acetate (Zoladex®)
  • Histrelin Acetate (Vantas®)
  • Leuprolide Acetate (Lupron®, Eligard®)
  • Triptorelin Pamoate (Trelstar®)

Drugs to Treat Bone Metastases

  • Alendronate (Fosamax®)
  • Denosumab (Xgeva®)
  • Pamidronate (Aredia®)
  • Zoledronic Acid (Zometa®) 


  • Radium 223 (Xofigo®)

For more information and support:

Last Reviewed: July 2017

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive